Back to Agenda
Q&A: Pre-Submitted Questions to the MHRA
Session Chair(s)
Louise Woodward, PhD
UK QPPV and Local Safety Responsible
Roche Products Ltd, United Kingdom
This session is dedicated to addressing participant questions about the pharmacovigilance aspects of the Windsor Framework. We have collected pre-submitted questions to ensure that we cover the most pressing topics. While our primary focus here is on pre-submitted questions, there will be an opportunity for live questions during the “Open Q&A from the Participants”.
Speaker(s)
Q&A: Pre-Submitted Questions to the MHRA
Claire Longman, MSc
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Expert Pharmacovigilance Inspector
Q&A: Pre-Submitted Questions to the MHRA
Sophie Radicke, MSc
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Head of GPvP and Senior Pharmacovigilance Inspector
Q&A: Pre-Submitted Questions to the MHRA
Stephanie Millican, PhD, MSc
MHRA, United Kingdom
Deputy Director Benefit Risk Evaluation, Safety and Surveillance
Have an account?